Suchergebnisse - "Visanji, Naomi P"

PubPharm (129)

51

α-Synuclein strains target distinct brain regions and cell types

enthalten in: Nature neuroscience | 2020

von Lau, A. | So, R. | Lau, H. | +18

CommentIn: Nat Rev Neurol. 2020 Feb;16(2):66. - PMID 31863058

52

Emerging drugs for the treatment of L-DOPA-induced dyskinesia: an update

enthalten in: Expert opinion on emerging drugs | 2020

von AlShimemeri, S. | Fox, S. | Visanji, N.

53

Identifying drugs with disease‐modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology

enthalten in: Pharmacoepidemiology and Drug Safety | 2020

von Maclagan, L. | Visanji, N. | Cheng, Y. | +5

54

Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease

enthalten in: Clinical autonomic research : official journal of the Clinical Autonomic Research Society | 2019

von Carricarte Naranjo, C. | Marras, C. | Visanji, N. | +9

55

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities

enthalten in: Translational neurodegeneration | 2019

von Visanji, N. | Lang, A. | Kovacs, G.

56

Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson’s disease

enthalten in: Clinical autonomic research | 2019

von Carricarte Naranjo, C. | Marras, C. | Visanji, N. | +9

57

Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson’s disease

enthalten in: Clinical autonomic research | 2019

von Carricarte Naranjo, C. | Marras, C. | Visanji, N. | +9

58

Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson’s disease

enthalten in: Clinical autonomic research | 2019

von Carricarte Naranjo, C. | Marras, C. | Visanji, N. | +9

59

Synchrotron XRF imaging of Alzheimer's disease basal ganglia reveals linear dependence of high-field magnetic resonance microscopy on tissue iron concentration

enthalten in: Journal of neuroscience methods | 2019

von Finnegan, M. | Visanji, N. | Romero-Canelon, I. | +6

60

Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease

enthalten in: Neuropharmacology | 2019

von Johnston, T. | Lacoste, A. | Visanji, N. | +3